HIV-1 antigens with discrete conformational forms in the V1/V2 domain and methods of use thereof
US9938325B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 6, 2013 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Sep 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel composition of HIV-1 Env proteins that contain structurally and immunologically distinct VI/V2 domains. Methods of isolating such proteins, and methods of using such proteins as immunogens, therapeutic agents, vaccines, and test compounds for use in identifying a HIV antiviral are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.